In the UK, Quadrise announced the signature of a collaboration and operational trial agreement with MSC Shipmanagement (MSC) and Cargill, paving the way for the trials on board the MSC Leandra.
Quadrise, MSC and Cargill have agreed their respective obligations under which the company’s fuels, bioMSAR and MSAR, will be produced at the MAC2 facility in Antwerp, Belgium using feedstocks supplied by Cargill and then sold by Cargill to MSC for the trials.
Under the agreement, Quadrise will provide equipment, additives and technical expertise; MSC will provide the trial vessel, MSC Leandra, necessary flag state approvals for the trials as well as professional monitoring services for the trials, while Cargill will be in charge of the provision of the necessary feedstocks, transportation of fuels and operational and logistical support.
Upon successful conclusion of the trials, MSC, Cargill and Quadrise will negotiate and enter into a definitive long-term commercial agreement.
Jason Miles, CEO of Quadrise, said: “Having already successfully demonstrated MSAR on the trial vessel, we are highly confident of a successful trial result on bioMSAR and the substantial commercial opportunities that this will lead to.”
More on the story.
